Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study

INTRODUCTION: Drug repurposing is the need of the hour considering the medical emergency caused by the COVID-19 pandemic. Recently, cytokine storm by the host immune system has been linked with high viral load, loss of lung function, acute respiratory distress syndrome (ARDS), multiple organ failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathak, Yamini, Mishra, Amaresh, Choudhir, Gourav, Kumar, Anuj, Tripathi, Vishwas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107206/
https://www.ncbi.nlm.nih.gov/pubmed/33970450
http://dx.doi.org/10.1007/s43440-021-00228-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107206/
https://www.ncbi.nlm.nih.gov/pubmed/33970450
http://dx.doi.org/10.1007/s43440-021-00228-0

Ejemplares similares